Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
TRAVOPROST
Actavis Group PTC ehf
S01EE04
TRAVOPROST
40 Microgram/ML
Eye Drops Solution
Product subject to prescription which may be renewed (B)
Prostaglandin analogues
Authorised
2014-11-14
PACKAGE LEAFLET: INFORMATION FOR THE USER BONDULC 40 MICROGRAMS/ML EYE DROPS, SOLUTION Travoprost READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Bondulc is and what it is used for 2. What you need to know before you use Bondulc 3. How to use Bondulc 4. Possible side effects 5. How to store Bondulc 6. Contents of the pack and other information 1. WHAT BONDULC IS AND WHAT IT IS USED FOR Bondulc CONTAINS TRAVOPROST, one of a group of medicines called PROSTAGLANDIN ANALOGUES. It works by reducing the pressure in the eye. It may be used on its own or with other drops e.g. beta-blockers, which also reduce pressure. Bondulc IS USED TO REDUCE HIGH PRESSURE IN THE EYE IN ADULTS, ADOLESCENTS AND CHILDREN FROM 2 MONTHS OLD ONWARD. This pressure can lead to an illness called GLAUCOMA. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE BONDULC DO NOT USE BONDULC IF YOU ARE ALLERGIC to travoprost or any of the other ingredients of this medicine (listed in section 6). Ask your doctor for advice if this applies to you. WARNINGS AND PRECAUTIONS BONDULCBondulc Bondulc MAY INCREASE the length, thickness, colour and/or number of your EYELASHES. Changes in the eyelids including unusual hair growth or Baca dokumen lengkap
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Bondulc 40 micrograms/ml eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 40 micrograms of Travoprost. Average active substance/drop: 0.97 - 1.4 µg Excipients with known effect: benzalkonium chloride 0.150 mg/ml, macrogol glycerol hydroxy stearate 40 5 mg/ml (see section 4.4.). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution. Clear, colourless solution. pH: 5.5-7.0 Osmolality: 266-294 mOsm/Kg 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Use in adults, including elderly population The dose is one drop of Bondulc in the conjunctival sac of the affected eye(s) once daily. Optimal effect is obtained if the dose is administered in the evening. Nasolacrimal occlusion or gently closing the eyelid after administration is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions. If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart (see section 4.5). If a dose is missed, treatment should be continued with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily. HEALTH PRODUCTS REGULATORY AUTHORITY __________________________________________________________________________________________________ Baca dokumen lengkap